Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma
Published inBritish journal of cancer, vol. 110, no. 11, p. 2655-2661
Publication date2014
Abstract
Keywords
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics/therapeutic use/toxicity
- Brain Neoplasms/mortality/therapy
- Chemoradiotherapy
- Dacarbazine/administration & dosage/analogs & derivatives
- Disease-Free Survival
- Female
- Glioblastoma/mortality/therapy
- Humans
- Male
- Maximum Tolerated Dose
- Middle Aged
- Niacinamide/administration & dosage/analogs & derivatives
- Phenylurea Compounds/administration & dosage
- Treatment Outcome
Citation (ISO format)
HOTTINGER, A F et al. Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma. In: British journal of cancer, 2014, vol. 110, n° 11, p. 2655–2661. doi: 10.1038/bjc.2014.209
Main files (1)
Article (Published version)
Updates (1)
Erratum
Identifiers
- PID : unige:90881
- DOI : 10.1038/bjc.2014.209
- PMID : 24786603
ISSN of the journal0007-0920